Patent · US Active

Vaccine

US10166279B2 · kind B2 · utility

0Cited by

2References

20Claims

0Family size

Assignees

Bergen Teknologioverføring AS · NO
The Administrators of the Tulane Educational Fund · US

Inventors

Pål Puntervoll · Bergen, NO
Halvor Sommerfelt · Bergen, NO
John D. Clements · New Orleans, US
James Nataro · Owings Mills, US
Weiping Zhang · Beijing, CN
Arne M. Taxt · Bergen, NO

Key dates

Filing date	Feb 20, 2014
Grant date	Jan 1, 2019
Priority date	—
Expiry date	Feb 20, 2034

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A mutant of an E coli heat-stable toxin (ST) having the following wild-type sequence: NSSNYCCELCCNPACTGCY wherein the mutant comprises a mutation selected from the group consisting of: A14H, A14T and N12T.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.